Genetics of ischaemic stroke in young adults

BBA Clinical

Volumn 3, Issue , 2015, Pages 96-106

  Terni, Eva ^a   Giannini, Nicola ^a   Brondi, Marco ^a   Montano, Vincenzo ^a   Bonuccelli, Ubaldo ^a   Mancuso, Michelangelo ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Genetics; GWAS; Stroke

Indexed keywords

ALPHA GALACTOSIDASE; ARGININE; ARYLDIALKYLPHOSPHATASE; CARNITINE; COLLAGEN TYPE 3; CORTICOSTEROID; CREATINE; FIBRILLIN 1; FIBRINOGEN RECEPTOR; IDEBENONE; LACTIC ACID; LINEZOLID; LIPOPROTEIN LIPASE; MATRIX METALLOPROTEINASE; METFORMIN; MITOCHONDRIAL DNA; PYRIDOXINE; UBIDECARENONE; VALPROIC ACID; VERY LATE ACTIVATION ANTIGEN 2;

BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CADASIL; CEREBROVASCULAR ACCIDENT; CONNECTIVE TISSUE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EDEMA; EHLERS DANLOS SYNDROME; FABRY DISEASE; FAMILIAL HEMIPLEGIC MIGRAINE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; GENETICS; HOMOCYSTINURIA; HUMAN; LIPID METABOLISM; MARFAN SYNDROME; META ANALYSIS (TOPIC); MONOGENIC DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; POLYGYNY; PREVALENCE; PRIORITY JOURNAL; PSEUDOXANTHOMA ELASTICUM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SICKLE CELL ANEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; X CHROMOSOME LINKED DISORDER;

EID: 84920973857     PISSN: 22146474     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbacli.2014.12.004     Document Type: Review

References (141)

1. Murray C.J., Lopez A.D. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997, 349:1436-1442.
2. Fratiglioni L., Launer L.J., Andersen K., Breteler M.M., Copeland J.R., Dartigues J.F., Lobo A., Martinez-Lage J., Soininen H., Hofman A. Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000, 54(11 Suppl. 5):S10-S15.
3. Lobo A., Launer L.J., Fratiglioni L., Andersen K., Di Carlo A., Breteler M.M., Copeland J.R., Dartigues J.F., Jagger C., Martinez-Lage J., Soininen H., Hofman A. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000, 54(11 Suppl. 5):S4-S9.
4. Schoenberg B.S., Kokmen E., Okazaki H. Alzheimer's disease and other demeting illnesses in a defined United States population: incidence rates and clinical features. Ann. Neurol. Dec 1987, 22(6):724-729.
5. Wolf M., Boyer-Neumann C., Martinoli J.L., Leroy-Matheron C., Amiral J., Meyer D., Larrieu M.J. A new functional assay for human protein S activity using activated factor V as substrate. Thromb. Haemost. Dec 29 1989, 62(4):1144-1145.
6. Di Carlo A., Inzitari D., Galati F., Baldereschi M., Giunta V., Grillo G., Furchì A., Manno V., Naso F., Vecchio A., Consoli D. A prospective community-based study of stroke in Southern Italy: the Vibo Valentia incidence of stroke study (VISS). Methodology, incidence and case fatality at 28days, 3 and 12months. Cerebrovasc. Dis. 2003, 16(4):410-417.
7. Marini C., Baldassarre M., Russo T., De Santis F., Sacco S., Ciancarelli I., Carolei A. Burden of first-ever ischemic stroke in the oldest old: evidence from a population-based study. Neurology Jan 13 2004, 62(1):77-81.
8. Correia M., Silva M.R., Matos I., Magalhães R., Lopes J.C., Ferro J.M., Silva M.C. Prospective community-based study of stroke in Northern Portugal: Incidence and case fatality in rural and urban populations. Stroke Sep 2004, 35(9):2048-2053. (Epub 2004 Jul 15).
9. Putaala J., Metso A.J., Metso T.M., et al. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke 2009, 40:1195-1203.
10. Baptista M.V., Ferreira S., Pinho-E-Melo T., Carvalho M., Cruz V.T., Carmona C., Silva F.A., Tuna A., Rodrigues M., Ferreira C., Pinto A.A., Leitão A., Gabriel J.P., Calado S., Oliveira J.P., Ferro J.M. Mutations of the GLA gene in young patients with stroke: The PORTYSTROKE study-screening genetic conditions in Portuguese young stroke patients. Stroke Mar 2010, 41(3):431-436. PORTuguese Young STROKE, Investigators.
11. Finsterer J. Management of cryptogenic stroke. Acta Neurol. Belg. Jun 2010, 110(2):135-147.
12. Dichgans M. Genetics of ischaemic stroke. Lancet Neurol. 2007, 6(2):149-161.
13. Bersano A., Ballabio E., Bresolin N., Candelise L. Genetic polymorphisms for the study of multifactorial stroke. Hum. Mutat. Jun 2008, 29(6):776-795.
14. Lindgren A. Stroke genetics: a review and update. J. Stroke Sep 2014, 16(3):114-123. (Epub 2014 Sep 30).
15. Hardy J., Singleton A. Genomewide association studies and human disease. N. Engl. J. Med. 2009, 360(17):1759-1768.
16. Jerrard-Dunne P., Cloud G., Hassan A., Markus H.S. Evaluating the genetic component of ischemic stroke subtypes: A family history study. Stroke Jun 2003, 34(6):1364-1369. (Epub 2003 Apr 24).
17. Jood K., Ladenvall P., Tjärnlund-Wolf A., Ladenvall C., Andersson M., Nilsson S., Blomstrand C., Jern C. Fibrinolytic gene polymorphism and ischemic stroke. Stroke Oct 2005, 36(10):2077-2081. (Epub 2005 Sep 22).
18. Bevan S., Traylor M., Adib-Samii P., Malik R., Paul N.L., Jackson C., Farrall M., Rothwell P.M., Sudlow C., Dichgans M., Markus H.S. Genetic heritability of ischemic stroke and the contribution of previously reported candidate gene and genomewide associations. Stroke Dec 2012, 43(12):3161-3167. (Epub 2012 Oct 4). 10.1161/STROKEAHA.112.665760.
19. Falcone G.J., Malik R., Dichgans M., Rosand J. Current concepts and clinical applications of stroke genetics. Lancet Neurol. Apr 2014, 13(4):405-418.
20. Ferro J.M., Massaro A.R., Mas J.-L. Aetiological diagnosis of ischaemic stroke in young adults. Lancet Neurol. 2010, 9:1085-1096.
21. Goto Y., Horai S., Matsuoka T., Koga Y., Nihei K., Kobayashi M., Nonaka I. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): A correlative study of the clinical features and mitochondrial DNA mutation. Neurology 1992, 42:545-550.
22. Kaufmann P., Engelstad K., Wei Y., Kulikova R., Oskoui M., Battista V., Koenigsberger D.Y., Pascual J.M., Sano M., Hirano M., DiMauro S., Shungu D.C., Mao X., De Vivo D.C. Protean phenotypic features of the A3243G mitochondrial DNA mutation. Arch. Neurol. 2009, 66(1):85-91.
23. Sharma P., Yadav S., Meschia J.F. Genetics of ischaemic stroke. J. Neurol. Neurosurg. Psychiatry 2013, 84:1302-1308.
24. Mancuso M., Orsucci D., Angelini C., Bertini E., Carelli V., Comi G.P., Minetti C., Moggio M., Mongini T., Servidei S., Tonin P., Toscano A., Uziel G., Bruno C., Caldarazzo Ienco E., Filosto M., Lamperti C., Martinelli D., Moroni I., Musumeci O., Pegoraro E., Ronchi D., Santorelli F.M., Sauchelli D., Scarpelli M., Sciacco M., Spinazzi M., Valentino M.L., Vercelli L., Zeviani M., Siciliano G. Phenotypic heterogeneity of the 8344A>G mtDNA "MERRF" mutation. Neurology May 28 2013, 80(22):2049-2054. (Epub 2013 May 1). 10.1212/WNL.0b013e318294b44c.
25. Mancuso M., Orsucci D., Coppedè F., Nesti C., Choub A., Siciliano G. Diagnostic approach to mitochondrial disorders: the need for a reliable biomarker. Curr. Mol. Med. Dec 2009, 9(9):1095-1107.
26. Deschauer M., Tennant S., Rokicka A., et al. MELAS associated with mutations in the POLG1 gene. Neurology 2007, 68(20):1741-1742.
27. Lonnqvist T., Paetau A., Valanne L., Pihko H. Recessive twinkle mutations cause severe epileptic encephalopathy. Brain 2009, 132(Pt 6):1553-1562.
28. Yoneda M., Maeda M., Kimura H., Fujii A., Katayama K., Kuriyama M. Vasogenic edema on MELAS: A serial study with diffusion-weighted MR imaging. Neurology Dec 10 1999, 53(9):2182-2184.
29. Ito H., Mori K., Harada M., Minato M., Naito E., Takeuchi M., Kuroda Y., Kagami S. Serial brain imaging analysis of stroke-like episodes in MELAS. Brain Dev. 2008, 30:483-488.
30. Testai F.D., Gorelick P.B. Inherited metabolic disorders and stroke part 1: Fabry disease and mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Arch. Neurol. Jan 2010, 67(1):19-24. 10.1001/archneurol.2009.309.
31. Betts J., Jaros E., Perry R.H., Schaefer A.M., Taylor R.W., Abdel-All Z., Lightowlers R.N., Turnbull D.M. Molecular neuropathology of MELAS: Level of heteroplasmy in individual neurones and evidence of extensive vascular involvement. Neuropathol. Appl. Neurobiol. 2006, 32(4):359-373.
32. Mancuso M., Orsucci D., Angelini C., Bertini E., Carelli V., Comi G.P., Donati A., Minetti C., Moggio M., Mongini T., Servidei S., Tonin P., Toscano A., Uziel G., Bruno C., Ienco E.C., Filosto M., Lamperti C., Catteruccia M., Moroni I., Musumeci O., Pegoraro E., Ronchi D., Santorelli F.M., Sauchelli D., Scarpelli M., Sciacco M., Valentino M.L., Vercelli L., Zeviani M., Siciliano G. The m.3243A>G mitochondrial DNA mutation and related phenotypes. A matter of gender?. J. Neurol. Mar 2014, 261(3):504-510.
33. Finsterer J. Management of mitochondrial stroke-like-episodes. Eur. J. Neurol. 2009, 16(11):1178-1184.
34. Santa K.M. Treatment options for mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome. Pharmacotherapy 2010, 30:1179-1196.
35. Koga Y., Povalko N., Nishioka J., Katayama K., Kakimoto N., Matsuishi T. MELAS and L-arginine therapy: Pathophysiology of stroke-like episodes. Ann. N. Y. Acad. Sci. 2010, 1201:104-110.
36. Mancuso M., Orsucci D., Filosto M., Simoncini C., Siciliano G. Drugs and mitochondrial diseases: 40 queries and answers. Expert. Opin. Pharmacother. Mar 2012, 13(4):527-543. (Epub 2012 Jan 31). 10.1517/14656566.2012.657177.
37. Rossi F.H., Okun M., Yachnis A., Quisling R., Triggs W.J. Corticosteroid treatment of mitochondrial encephalomyopathies. Neurologist 2002, 8(5):313-315.
38. Rodriguez M.C., MacDonald J.R., Mahoney D.J., Parise G., Beal M.F., Tarnopolsky M.A. Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders. Muscle Nerve 2007, 35:235-242.
39. Razvi S., Bone I. Single gene disorders causing ischaemic stroke. J. Neurol. 2006, 253(6):685-700.
40. Federico A., Di Donato I., Bianchi S., et al. Hereditary cerebral small vessel diseases: A review. J. Neurol. Sci. 2012, 322(1-2):25-30.
41. Chabriat H., Joutel A., Dichgans M., Tournier-Lasserve E., Bousser M.G. Cadasil. Lancet Neurol. 2009, 8(7):643-653.
42. Valenti R., Poggesi A., Pescini F., Inzitari D., Pantoni L. Psychiatric disturbances in CADASIL: A brief review. Acta Neurol. Scand. Nov 2008, 118(5):291-295. (Epub 2008 Mar 26). 10.1111/j.1600-0404.2008.01015.x.
43. Herve D., Chabriat H. Cadasil. J. Geriatr. Psychiatry Neurol. 2010, 23:269-276.
44. Ayata C. CADASIL: Experimental insights from animal models. Stroke 2010, 41:S129-S134.
45. Dong Y., Hassan A., Zhang Z., Huber D., Dalageorgou C., Markus H.S. Yield of screening for CADASIL mutations in lacunar stroke and leukoaraiosis. Stroke Jan 2003, 34(1):203-205.
46. Chabriat H., Pappata S., Ostergaard L., Clark C.A., Pachot-Clouard M., Vahedi K., Jobert A., Le Bihan D., Bousser M.G. Cerebral hemodynamics in CADASIL before and after acetazolamide challenge assessed with MRI bolus tracking. Stroke 2000, 31:1904-1912.
47. O'Sullivan M1., Jarosz J.M., Martin R.J., Deasy N., Powell J.F., Markus H.S. MRI hyperintensities of the temporal obe and external capsule in patients with CADASIL. Neurology 2001, 56:628-634.
48. Meschia J.F., Brott T.G., Brown R.D.J. Genetics of cerebrovascular disorders. Mayo Clin. Proc. 2005, 80(1):122-132.
49. Fukutake T. Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): From discovery to gene identification. J. Stroke Cerebrovasc. Dis. 2011, 20:85-93.
50. Arima K., Yanagawa S., Ito N., Ikeda S. Cerebral arterial pathology of CADASIL and CARASIL (Maeda syndrome). Neuropathology 2003, 23:327-334.
51. Germain D.P. Fabry disease. Orphanet J. Rare Dis. 2010, 5:30.
52. Zarate Y.A., Hopkin R.J. Fabry's disease. Lancet 2008, 372(9647):1427-1435.
53. Toyooka K. Fabry disease. Curr. Opin. Neurol. 2011, 24:463-468.
54. Buechner S., Moretti M., Burlina A.P., Cei G., Manara R., Ricci R., Mignani R., Parini R., Di Vito R., Giordano G.P., Simonelli P., Siciliano G., Borsini W. Central nervous system involvement in Anderson-Fabry disease: A clinical and MRI retrospective study. J. Neurol. Neurosurg. Psychiatry 2008, 79(11):1249-1254.
55. Salviati A., Burlina A.P., Borsini W. Nervous system and Fabry disease, from symptoms to diagnosis: Damage evaluation and follow-up in adult patients, enzyme replacement, and support therapy. Neurol. Sci. 2010, 31(3):299-306.
56. Fellgiebel A., Muller M.J., Ginsberg L. CNS manifestations of Fabry's disease. Lancet Neurol. 2006, 5(9):791-795.
57. Fellgiebel A., Keller I., Marin D., Müller M.J., Schermuly I., Yakushev I., Albrecht J., Bellhäuser H., Kinateder M., Beck M., Stoeter P. Diagnostic utility of different MRI and MR angiography measures in Fabry disease. Neurology 2009, 72:63-68.
58. Simoncini C., Orsucci D., Gori S., Giorgi F.S., Cosottini M., Siciliano G., Mancuso M. Fabry disease with atypical neurological presentation: Report of a case. Neurologist 2012, 18(6):413-414.
59. Linthorst G.E., Bouwman M.G., Wijburg F.A., Aerts J.M., Poorthuis B.J., Hollak C.E. Screening for Fabry disease in high-risk populations: A systematic review. J. Med. Genet. Apr 2010, 47(4):217-222. (Epub 2009 Sep 24). 10.1136/jmg.2009.072116.
60. Furie K.L., Kasner S.E., Adams R.J., Albers G.W., Bush R.L., Fagan S.C., Halperin J.L., Johnston S.C., Katzan I., Kernan W.N., Mitchell P.H., Ovbiagele B., Palesch Y.Y., Sacco R.L., Schwamm L.H., Wassertheil-Smoller S., Turan T.N., Wentworth D. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: A guideline for healthcare professionals for the American heart association/American stroke association. Stroke 2011, 42:227-276. American Heart Association Stroke Council, Council on Cardiovascular NursingCouncil on Cardiovascular Nursing, Council on Clinical CardiologyCouncil on Clinical Cardiology, Interdisciplinary Council on Quality of Care and Outcomes ResearchInterdisciplinary Council on Quality of Care and Outcomes Research.
61. Germain D.P. Fabry disease: the need to stratify patient populations to better understand the outcome of enzyme replacement therapy. Clin. Ther. 2007, 29(Suppl. A):S17-S18.
62. Lanfranconi S., Markus H.S. COL4A1 mutations as a monogenic cause of cerebral small vessel disease: A systematic review. Stroke 2010, 41(8):e513-e518.
63. Zhou Q., Yang D., Ombrello A.K., Zavialov A.V., Toro C., Zavialov A.V., Stone D.L., Chae J.J., Rosenzweig S.D., Bishop K., Barron K.S., Kuehn H.S., Hoffmann P., Negro A., Tsai W.L., Cowen E.W., Pei W., Milner J.D., Silvin C., Heller T., Chin D.T., Patronas N.J., Barber J.S., Lee C.C., Wood G.M., Ling A., Kelly S.J., Kleiner D.E., Mullikin J.C., Ganson N.J., Kong H.H., Hambleton S., Candotti F., Quezado M.M., Calvo K.R., Alao H., Barham B.K., Jones A., Meschia J.F., Worrall B.B., Kasner S.E., Rich S.S., Goldbach-Mansky R., Abinun M., Chalom E., Gotte A.C., Punaro M., Pascual V., Verbsky J.W., Torgerson T.R., Singer N.G., Gershon T.R., Ozen S., Karadag O., Fleisher T.A., Remmers E.F., Burgess S.M., Moir S.L., Gadina M., Sood R., Hershfield M.S., Boehm M., Kastner D.L., Aksentijevich I. Early-onset stroke and vasculopathy associated with mutations in ADA2. N. Engl. J. Med. 2014, 370:911-920.
64. Vanakker O.M., Hemelsoet D., De Paepe A. Hereditary connective tissue diseases in young adult stroke: A comprehensive synthesis. Stroke Res. Treat. 2011, 2011:712903.
65. Romaniello F., Mazzaglia D., Pellegrino A., Grego S., Fiorito R., Ferlosio A., Chiariello L., Orlandi A. Aortopathy in Marfan syndrome: An update. Cardiovasc. Pathol. 2014, 23:261-266.
66. Uitto J., Bercovitch L., Terry S.F., Terry P.F. Pseudoxanthoma elasticum: progress in diagnostics and research towards treatment: Summary of the 2010 PXE International Research Meeting. Am. J. Med. Genet. A Jul 2011, 155A(7):1517-1526.
67. Hankey G.J., Eikelboom J.W. Homocysteine levels in patients with stroke: Clinical relevance and therapeutic implications. CNS Drugs 2001, 15(6):437-443.
68. Wald N.J., Law M., Haddow J.E., Craig W.Y. Apolipoproteins and prediction of fatal myocardial infarction. Lancet May 25 2002, 359(9320):1864.
69. Casas J.P., Bautista L.E., Smeeth L., Sharma P., Hingorani A.D. Homocysteine and stroke: Evidence on a causal link from mendelian randomization. Lancet 2005, 365:224-232.
70. Guo J.M., Liu A.J., Su D.F. Genetics of stroke. Acta Pharmacol. Sin. 2010, 31:1055-1064.
71. Agerholm-Larsen B., Tybjaerg-Hansen A., Frikke-Schmidt R., Grønholdt M.L., Jensen G., Nordestgaard B.G. ACE gene polymorphism as a risk factor for ischemic cerebrovascular disease. Ann. Intern. Med. Sep 1 1997, 127(5):346-355.
72. Pfohl M., Fetter M., Koch M., Barth C.M., Rudiger W., Haring H.U. Association between angiotensin I-converting enzyme genotypes, extracranial artery stenosis and stroke. Atherosclerosis Sep 1998, 140(1):161-166.
73. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. Oct 1990, 86(4):1343-1346.
74. Cambien F., Poirier O., Lecerf L., Evans A., Cambou J.P., Arveiler D., Luc G., Bard J.M., Bara L., Ricard S., et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature Oct 15 1992, 359(6396):641-644.
75. Tuncer N., Tuglular S., Kiliç G., Sazci A., Us O., Kara I. Evaluation of the angiotensin-converting enzyme insertion/deletion polymorphism and the risk of ischemic stroke. J. Clin. Neurosci. 2006, 13:224-227.
76. Reid I.A. The renin-angiotensin system: physiology, pathophysiology, and pharmacology. Adv. Physiol. Educ. 1998, 275:236-245.
77. Van Rijn M.J., Schut A.F., Aulchenko Y.S., Deinum J., Sayed-Tabatabaei F.A., Yazdanpanah M., Isaacs A., Axenovich T.I., Zorkoltseva I.V., Zillikens M.C., Pols H.A., Witteman J.C., Oostra B.A., van Duijn C.M. Heritability of blood pressure traits and the genetic contribution to blood pressure variance explained by four blood-pressure-related genes. J. Hypertens. Mar 2007, 25(3):565-570.
78. Katsuya T., Ishikawa K., Sugimoto K., Rakugi H., Ogihara T. Salt sensitivity of Japanese from the viewpoint of gene polymorphism. Hypertens. Res. 2003, 26:521-525.
79. Poort S.R., Rosendaal F.R., Reitsma P.H., Bertina R.M. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood Nov 15 1996, 88(10):3698-3703.
80. Sykes T.C., Fegan C., Mosquera D. Trombophilia, polymorphisms, and vascular disease. Mol. Pathol. Dec 2000, 53(6):300-306.
81. Endler G., Mannhalter C. Polymorphisms in coagulation factor genes and their impact on arterial and venous thrombosis. Clin. Chim. Acta Apr 2003, 330(1-2):31-55. (Review).
82. Girolami A., Simioni P., Scarano L., Carraro G. Prothrombin and the prothrombin 20210G to A polymorphism: their relationship with hypercoagulability and thrombosis. Blood Rev. Dec 1999, 13(4):205-210. (Review).
83. Casas J.P., Hingorani A.D., Bautista L.E., Sharma P. Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch. Neurol. Nov 2004, 61(11):1652-1661.
84. Wilhelmsen L., Svardsudd K., Korsan-Bengtsen K., Larsson B., Welin L., Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N. Engl. J. Med. Aug 23 1984, 311(8):501-505.
85. Kalafatis M., Rand M.D., Mann K.G. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J. Biol. Chem. Dec 16 1994, 269(50):31869-31880.
86. Funk M., Endler G., Lalouschek W., Hsieh K., Schillinger M., Lang W., Mannhalter C. Factor VII gene haplotypes and risk of ischemic stroke. Clin. Chem. 2006, 52:1190-1192.
87. Berger K., Stogbauer F., Stoll M., Wellmann J., Huge A., Cheng S., Kessler C., John U., Assmann G., Ringelstein E.B., Funke H. The glu298asp polymorphism in the nitric oxide synthase 3 gene is associated with the risk of ischemic stroke in two large independent case-control studies. Hum. Genet. 2007, 121:169-178.
88. Yeh P.S., Lin H.J., Li Y.H., Lin K.C., Cheng T.J., Chang C.Y., Ke D.S. Prognosis of young ischemic stroke in Taiwan: Impact of prothrombotic genetic polymorphism. Thromb. Haemost. 2004, 92:583-589.
89. Kanaji T., Okamura T., Osaki K., Kuroiwa M., Shimoda K., Hamasaki N., Niho Y. A common genetic polymorphism (46 C to T substitution) in the 5'-untranslated region of the coagulation factor XII gene is associated with low translation efficiency and decrease in plasma factor XII level. Blood Mar 15 1998, 91(6):2010-2014.
90. Tirado I., Soria J.M., Mateo J., Oliver A., Souto J.C., Santamaria A., Felices R., Borrell M., Fontcuberta J. Association after linkage analysis indicates that homozygosity for the 46C->T polymorphism in the F12 gene is a genetic risk factor for venous thrombosis. Thromb. Haemost. May 2004, 91(5):899-904.
91. Zeerleder S., Schloesser M., Redondo M., Wuillelmin W.A., Engel W., Furlan M., Lammle B. Reevaluation of the incidence of thromboembolic complications in congenital factor XII deficiency - a study on 73 subjects from 14 Swiss families. Thromb. Haemost. Oct 1999, 82(4):1240-1246.
92. Zito F., Lowe G.D., Rumley A., McMahon A.D., Humphries S.E. WOSCOPS Study Group West of Scotland Coronary Prevention Study. Atherosclerosis Nov 2002, 165(1):153-158.
93. Dai K., Gao W., Ruan C. The SmaI polymorphism in the von Willebrand Factor gene associated with acute ischemic stroke. Thromb. Res. 2001, 104:389-395.
94. Schneiderman J., Sawdey M.S., Keeton M.R., Bordin G.M., Bernstein E.F., Dilley R.B., Loskutoff D.J. Increased type I plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc. Natl. Acad. Sci. U. S. A. Aug 1 1992, 89(15):6998-7002.
95. Thögersen A.M., Jansson J.H., Boman K., Nilsson T.K., Weinehall L., Huhtasaari F., Hallmans G. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: Evidence for the fibrinolytic system as an independent primary risk factor. Circulation Nov 24 1998, 98(21):2241-2247.
96. Lane D.A., Grant P.J. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood Mar 1 2000, 95(5):1517-1532. (Review).
97. Ding J., Nicklas B.J., Fallin M.D., de Rekeneire N., Kritchevsky S.B., Pahor M., Rodondi N., Li R., Zmuda J.M., Harris T.B. Plasminogen activator inhibitor type 1 gene polymorphisms and haplotypes are associated with plasma plasminogen activator inhibitor type 1 levels but not with myocardial infarction or stroke. Am. Heart J. Dec 2006, 152(6):1109-1115.
98. Reiner A.P., Siscovick D.S., Rosentaal F.R. Platelet glycoprotein gene polymorphisms and risk of thrombosis: Facts and fancies. Rev. Clin. Exp. Hematol. Sep 2001, 5(3):262-287.
99. Zhang Y., Wang Y., Cui C., Hiang P., Li X., Liu S., Lendon C., Guo N. Platelet glycoprotein polymorphisms: Risk, in vivo expression and severity of atherothrombotic stroke in Chinese. Clin. Chim. Acta 2007, 378:99-104.
100. Carter A.M., Catto A.J., Bamford J.M., Grant P.J. Association of the platelet glycoprotein IIb HPA-3 polymorphism with survival after acute ischemic stroke. Stroke Dec 1999, 30(12):2606-2611.
101. Reiner A.P., Kumar P.N., Schwartz S.M., Longstreth W.T., Pearce R.M., Rosendaal F.R., Psaty B.M., Siscovick D.S. Genetic variants of platelet glycoprotein receptors and risk of stroke in young women. Stroke 2000, 31:1628-1633.
102. Carlsson L.E., Santoso S., Spitzer C., Kessler C., Greinacher A. The alpha2 gene coding sequence T807/A873 of the platelet collagen receptor integrin alpha2beta1 might be a genetic risk factor for the development of stroke in younger patients. Blood Jun 1 1999, 93(11):3583-3586.
103. Reiner A.P., Schwartz S.M., Frank M.B., Longstreth W.T., Hindorff L.A., Teramura G., Rosentaal F.R., Gaur L.K., Psaty B.M., Siscovick D.S. Polymorphisms of coagulation factor XIII subunit A and risk of nonfatal hemorrhagic stroke in young white women. Stroke Nov 2001, 32(11):2580-2586.
104. Kuijpers R.W., Faber N.M., Cuypers H.T., Ouwehand W.H., Von Dem Borne A.E. NH2-terminal globular domain of human platelet glycoprotein Ib alpha has a methionine 145/threonine145 amino acid polymorphism, which is associated with the HPA-2 (Ko) alloantigens. J. Clin. Invest. Feb 1992, 89(2):381-384.
105. Sonoda A., Murata M., Ito D., Tanahashi N., Ohta A., Tada Y., Takeshita E., Yoshida T., Saito I., Yamamoto M., Ikeda Y., Fukuuchi Y., Watanabe K. Association between platelet glycoprotein Ibalpha genotype and ischemic cerebrovascular disease. Stroke Feb 2000, 31(2):493-497.
106. Sonoda A., Murata M., Ikeda Y., Fukuuchi Y., Watanabe K. Stroke and platelet glycoprotein Ibalpha polymorphisms. Thromb. Haemost. Mar 2001, 85(3):573-574.
107. Hsieh M.M., Fitzhugh C.D., Weitzel R.P., Link M.E., Coles W.A., Zhao X., Rodgers G.P., Powell J.D., Tisdale J.F. Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype. JAMA Jul 2 2014, 312(1):48-56.
108. Tasdemir N., Tamam Y., Toprak R., Tamam B., Tasdemir M.S. Association of apolipoprotein E genotype and cerebrovascular disease risk factors in a Turkish population. Int. J. Neurosci. 2008, 118:1109-1129.
109. Lai C.L., Liu C.K., Lin R.T., Tai C.T. Association of apolipoprotein E polymorphism with ischemic stroke subtypes in Taiwan. Kaohsiung J. Med. Sci. Oct 2007, 23(10):491-497.
110. Debette S., Lambert J.C., Gariépy J., Fievet N., Tzourio C., Dartigues J.F., Ritchie K., Dupuy A.M., Alpérovitch A., Ducimetière P., Amouyel P., Zureik M. New insight into the association of apolipoprotein E genetic variants with carotid plaques and intima-media thickness. Stroke 2006, 37:2917-2923.
111. Lemmens R., Görner A., Schrooten M., Thijs V. Association of apolipoprotein E epsilon2 with white matter disease but not with microbleeds. Stroke 2007, 38:1185-1188.
112. Beisiegel U., Weber W., Bengtsson-Olivecrona G. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc. Natl. Acad. Sci. U. S. A. Oct 1 1991, 88(19):8342-8346.
113. Eckel R.H. Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. N. Engl. J. Med. Apr 20 1989, 320(16):1060-1068. (Review).
114. Kim N.S., Kang K., Cha M.H., Kang B.J., Moon J., Kang B.K., Yu B.C., Kim Y.S., Choi S.M., Bang O.S. Decreased paraoxonase-1 activity is a risk factor for ischemic stroke in Koreans. Biochem. Biophys. Res. Commun. Dec 7 2007, 364(1):157-162. (Epub 2007 Oct 4).
115. Fornage M., Mosley T.H., Jack C.R., de Andrade M., Kardia S.L., Boerwinkle E., Turner S.T. Family-based association study of matrix metalloproteinase-3 and -9 haplotypes with susceptibility to ischemic white matter injury. Hum. Genet. 2007, 120:671-680.
116. Humphries S.E., Morgan L. Genetic risk factors for stroke and carotid atherosclerosis: Insights into pathophysiology from candidate gene approaches. Lancet Neurol. 2004, 3:227-236.
117. Kaplan R.C., Smith N.L., Zucker S., Heckbert S.R., Rice K., Psaty B.M. Matrix metalloproteinase-3 (MMP3) and MMP9 genes and risk of myocardial infarction, ischemic stroke, and hemorrhagic stroke. Atherosclerosis 2008, 201:130-137.
118. Markus H.S. Wellcome Trust Genome-Wide Association Study of Ischemic Stroke. Stroke 2013, 44:S20-S22.
119. Bevan S., Markus H.S. Genetics of common polygenic ischaemic stroke: Current understanding and future challenges. Stroke Res. Treat. 2011, 179061.
120. Gudbjartsson D.F., Arnar D.O., Helgadottir A., Gretarsdottir S., Holm H., Sigurdsson A., Jonasdottir A., Baker A., Thorleifsson G., Kristjansson K., Palsson A., Blondal T., Sulem P., Backman V.M., Hardarson G.A., Palsdottir E., Helgason A., Sigurjonsdottir R., Sverrisson J.T., Kostulas K., Ng M.C., Baum L., So W.Y., Wong K.S., Chan J.C., Furie K.L., Greenberg S.M., Sale M., Kelly P., MacRae C.A., Smith E.E., Rosand J., Hillert J., Ma R.C., Ellinor P.T., Thorgeirsson G., Gulcher J.R., Kong A., Thorsteinsdottir U., Stefansson K. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 2007, 448(7151):353-357.
121. Lemmens R., Buysschaert I., Geelen V., Fernandez-Cadenas I., Montaner J., Schmidt H., Schmidt R., Attia J., Maguire J., Levi C., Jood K., Blomstrand C., Jern C., Wnuk M., Slowik A., Lambrechts D., Thijs V. The association of the 4q25 susceptibility variant for atrial fibrillation with stroke is limited to stroke of cardioembolic etiology. Stroke Sep 2010, 41:1850-1857. International Stroke Genetics Consortium.
122. Luo M., Li J.X., Sun X.S., Lai R., Wang Y.F., Xu X.W., Sheng W.L. The single nucleotide polymorphism rs2208454 confers an increased risk for ischemic stroke: A case-control study. CNS Neurosci. Ther. Oct 2014, 20(10):893-897.
123. Gretarsdottir S., Thorleifsson G., Manolescu A., Styrkarsdottir U., Helgadottir A., Gschwendtner A., Kostulas K., Kuhlenbäumer G., Bevan S., Jonsdottir T., Bjarnason H., Saemundsdottir J., Palsson S., Arnar D.O., Holm H., Thorgeirsson G., Valdimarsson E.M., Sveinbjörnsdottir S., Gieger C., Berger K., Wichmann H.E., Hillert J., Markus H., Gulcher J.R., Ringelstein E.B., Kong A., Dichgans M., Gudbjartsson D.F., Thorsteinsdottir U., Stefansson K. Risak variants for atrial fibrillation on chromosome 4q25 associate with ischaemic stroke. Ann. Neurol. 2008, 64(4):402-409.
124. Schunkert H., Götz A., Braund P., McGinnis R., Tregouet D.A., Mangino M., Linsel-Nitschke P., Cambien F., Hengstenberg C., Stark K., Blankenberg S., Tiret L., Ducimetiere P., Keniry A., Ghori M.J., Schreiber S., El Mokhtari N.E., Hall A.S., Dixon R.J., Goodall A.H., Liptau H., Pollard H., Schwarz D.F., Hothorn L.A., Wichmann H.E., König I.R., Fischer M., Meisinger C., Ouwehand W., Deloukas P., Thompson J.R., Erdmann J., Ziegler A., Samani N.J. Cardiogenics consortium. Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation 2008, 117(13):1675-1684.
125. International Stroke Genetics Consortium (ISGC)1, Wellcome Trust Case Control Consortium 2 (WTCCC2), Bellenguez C., Bevan S., Gschwendtner A., Spencer C.C., Burgess A.I., Pirinen M., Jackson C.A., Traylor M., Strange A., Su Z., Band G., Syme P.D., Malik R., Pera J., Norrving B., Lemmens R., Freeman C., Schanz R., James T., Poole D., Murphy L., Segal H., Cortellini L., Cheng Y.C., Woo D., Nalls M.A., Müller-Myhsok B., Meisinger C., Seedorf U., Ross-Adams H., Boonen S., Wloch-Kopec D., Valant V., Slark J., Furie K., Delavaran H., Langford C., Deloukas P., Edkins S., Hunt S., Gray E., Dronov S., Peltonen L., Gretarsdottir S., Thorleifsson G., Thorsteinsdottir U., Stefansson K., Boncoraglio G.B., Parati E.A., Attia J., Holliday E., Levi C., Franzosi M.G., Goel A., Helgadottir A., Blackwell J.M., Bramon E., Brown M.A., Casas J.P., Corvin A., Duncanson A., Jankowski J., Mathew C.G., Palmer C.N., Plomin R., Rautanen A., Sawcer S.J., Trembath R.C., Viswanathan A.C., Wood N.W., Worrall B.B., Kittner S.J., Mitchell B.D., Kissela B., Meschia J.F., Thijs V., Lindgren A., Macleod M.J., Slowik A., Walters M., Rosand J., Sharma P., Farrall M., Sudlow C.L., Rothwell P.M., Dichgans M., Donnelly P., Markus H.S. Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat. Genet. Feb 5 2012, 44(3):328-333.
126. Traylor M., Farrall M., Holliday E.G., Sudlow C., Hopewell J.C., Cheng Y.C., Fornage M., Ikram M.A., Malik R., Bevan S., Thorsteinsdottir U., Nalls M.A., Longstreth W., Wiggins K.L., Yadav S., Parati E.A., Destefano A.L., Worrall B.B., Kittner S.J., Khan M.S., Reiner A.P., Helgadottir A., Achterberg S., Fernandez-Cadenas I., Abboud S., Schmidt R., Walters M., Chen W.M., Ringelstein E.B., O'Donnell M., Ho W.K., Pera J., Lemmens R., Norrving B., Higgins P., Benn M., Sale M., Kuhlenbäumer G., Doney A.S., Vicente A.M., Delavaran H., Algra A., Davies G., Oliveira S.A., Palmer C.N., Deary I., Schmidt H., Pandolfo M., Montaner J., Carty C., de Bakker P.I., Kostulas K., Ferro J.M., van Zuydam N.R., Valdimarsson E., Nordestgaard B.G., Lindgren A., Thijs V., Slowik A., Saleheen D., Paré G., Berger K., Thorleifsson G., Australian Stroke Genetics Collaborative, Wellcome Trust Case Control Consortium 2 (WTCCC2), Hofman A., Mosley T.H., Mitchell B.D., Furie K., Clarke R., Levi C., Seshadri S., Gschwendtner A., Boncoraglio G.B., Sharma P., Bis J.C., Gretarsdottir S., Psaty B.M., Rothwell P.M., Rosand J., Meschia J.F., Stefansson K., Dichgans M., Markus H.S. Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol. Nov 2012, 11(11):951-962. International Stroke Genetics Consortium.
127. Ikram M.A., Seshadri S., Bis J.C., Fornage M., DeStefano A.L., Aulchenko Y.S., Debette S., Lumley T., Folsom A.R., Van Den Herik E.G., Bos M.J., Beiser A., Cushman M., Launer L.J., Shahar E., Struchalin M., Du Y., Glazer N.L., Rosamond W.D., Rivadeneira F., Kelly-Hayes M., Lopez O.L., Coresh J., Hofman A., DeCarli C., Heckbert S.R., Koudstaal P.J., Yang Q., Smith N.L., Kase C.S., Rice K., Haritunians T., Roks G., de Kort P.L., Taylor K.D., de Lau L.M., Oostra B.A., Uitterlinden A.G., Rotter J.I., Boerwinkle E., Psaty B.M., Mosley T.H., van Duijn C.M., Breteler M.M., Longstreth W.T., Wolf P.A. Genomewide association studies of stroke. N. Eng. J. Med. 2009, 360:1718-1728.
128. Wang L., Zhao C., Xia Q.X., Qiao S.J. Association between 12p13 SNP rs11833579 and ischemic stroke in Asian population: An updated meta-analysis. J. Neurol. Sci. Oct 15 2014, 345(1-2):198-201.
129. Debette S., Bis J.C., Fornage M., Schmidt H., Ikram M.A., Sigurdsson S., Heiss G., Struchalin M., Smith A.V., van der Lugt A., DeCarli C., Lumley T., Knopman D.S., Enzinger C., Eiriksdottir G., Koudstaal P.J., DeStefano A.L., Psaty B.M., Dufouil C., Catellier D.J., Fazekas F., Aspelund T., Aulchenko Y.S., Beiser A., Rotter J.I., Tzourio C., Shibata D.K., Tscherner M., Harris T.B., Rivadeneira F., Atwood L.D., Rice K., Gottesman R.F., van Buchem M.A., Uitterlinden A.G., Kelly-Hayes M., Cushman M., Zhu Y., Boerwinkle E., Gudnason V., Hofman A., Romero J.R., Lopez O., van Duijn C.M., Au R., Heckbert S.R., Wolf P.A., Mosley T.H., Seshadri S., Breteler M.M., Schmidt R., Launer L.J., Longstreth W.T. Genome-wide association studies of MRI-defined brain infarcts: Meta-analysis from the CHARGE-consortium. Stroke 2010, 41:210-217.
130. Williams S.R., Yang Q., Chen F., Liu X., Keene K.L., Jacques P., Chen W.M., Weinstein G., Hsu F.C., Beiser A., Wang L., Bookman E., Doheny K.F., Wolf P.A., Zilka M., Selhub J., Nelson S., Gogarten S.M., Worrall B.B., Seshadri S., Sale M.M. Genomics and Randomized Trials Network; Framingham Heart Study. Genome-wide meta-analysis of homocysteine and methionine metabolism identifies five one carbon metabolism loci and a novel association of ALDH1L1 with ischemic stroke. PLoS Genet. Mar 20 2014, 10(3):e1004214.
131. Zhang Y., Tong Y., Zhang Y., Ding H., Zhang H., Geng Y., Zhang R., Ke Y., Han J., Yan Z., Zhou L., Wu T., Hu F.B., Wang D., Cheng J. Two novel susceptibility SNPs for ischemic stroke using exome sequencing in Chinese Han population. Mol. Neurobiol. Apr 2014, 49(2):852-862.
132. Kilarski L.L., Achterberg S., Devan W.J., Traylor M., Malik R., Lindgren A., Pare G., Sharma P., Slowik A., Thijs V., Walters M., Worrall B.B., Sale M.M., Algra A., Kappelle L.J., Wijmenga C., Norrving B., Sandling J.K., Rönnblom L., Goris A., Franke A., Sudlow C., Rothwell P.M., Levi C., Holliday E.G., Fornage M., Psaty B., Gretarsdottir S., Thorsteinsdottir U., Seshadri S., Mitchell B.D., Kittner S., Clarke R., Hopewell J.C., Bis J.C., Boncoraglio G.B., Meschia J., Ikram M.A., Hansen B.M., Montaner J., Thorleifsson G., Stefanson K., Rosand J., de Bakker P.I., Farrall M., Dichgans M., Markus H.S., Bevan S. Meta-analysis in more than 17,900 cases of ischemic stroke reveals a novel association at 12q24.12. Neurology Aug 19 2014, 83(8):678-685. GARNET Collaborative Research Group, Wellcome Trust Case Control Consortium 2Wellcome Trust Case Control Consortium 2, Australian Stroke Genetic CollaborativeAustralian Stroke Genetic Collaborative, the METASTROKE Consortiumthe METASTROKE Consortium, the International Stroke Genetics Consortiumthe International Stroke Genetics Consortium.
133. Traylor M., Mäkelä K.M., Kilarski L.L., Holliday E.G., Devan W.J., Nalls M.A., Wiggins K.L., Zhao W., Cheng Y.C., Achterberg S., Malik R., Sudlow C., Bevan S., Raitoharju E., METASTROKE, International Stroke Genetics Consortium, Wellcome Trust Case Consortium 2 (WTCCC2), Oksala N., Thijs V., Lemmens R., Lindgren A., Slowik A., Maguire J.M., Walters M., Algra A., Sharma P., Attia J.R., Boncoraglio G.B., Rothwell P.M., de Bakker P.I., Bis J.C., Saleheen D., Kittner S.J., Mitchell B.D., Rosand J., Meschia J.F., Levi C., Dichgans M., Lehtimäki T., Lewis C.M., Markus H.S. A novel MMP12 locus is associated with large artery atherosclerotic stroke using a genome-wide age-at-onset informed approach. PLoS Genet. Jul 31 2014, 10(7):e1004469.
134. Arning A., Hiersche M., Witten A., Kurlemann G., Kurnik K., Manner D., Stoll M., Nowak-Göttl U. A genome-wide association study identifies a gene network of ADAMTS genes in the predisposition to pediatric stroke. Blood Dec 20 2012, 120(26):5231-5236.
135. Ibrahim-Verbaas C.A., Fornage M., Bis J.C., Choi S.H., Psaty B.M., Meigs J.B., Rao M., Nalls M., Fontes J.D., O'Donnell C.J., Kathiresan S., Ehret G.B., Fox C.S., Malik R., Dichgans M., Schmidt H., Lahti J., Heckbert S.R., Lumley T., Rice K., Rotter J.I., Taylor K.D., Folsom A.R., Boerwinkle E., Rosamond W.D., Shahar E., Gottesman R.F., Koudstaal P.J., Amin N., Wieberdink R.G., Dehghan A., Hofman A., Uitterlinden A.G., Destefano A.L., Debette S., Xue L., Beiser A., Wolf P.A., Decarli C., Ikram M.A., Seshadri S., Mosley T.H., Longstreth W.T., van Duijn C.M., Launer L.J. Predicting stroke through genetic risk functions: the CHARGE Risk Score Project. Stroke Feb 2014, 45(2):403-412.
136. Meschia J.F., Arnett D.K., Ay H., Brown R.D., Benavente O.R., Cole J.W., de Bakker P.I., Dichgans M., Doheny K.F., Fornage M., Grewal R.P., Gwinn K., Jern C., Conde J.J., Johnson J.A., Jood K., Laurie C.C., Lee J.M., Lindgren A., Markus H.S., McArdle P.F., McClure L.A., Mitchell B.D., Schmidt R., Rexrode K.M., Rich S.S., Rosand J., Rothwell P.M., Rundek T., Sacco R.L., Sharma P., Shuldiner A.R., Slowik A., Wassertheil-Smoller S., Sudlow C., Thijs V.N., Woo D., Worrall B.B., Wu O., Kittner S.J. Stroke Genetics Network (SiGN) study: Design and rationale for a genome-wide association study of ischemic stroke subtypes. Stroke Oct 2013, 44:2694-2702. NINDS SiGN Study.
137. Mallolas J., Hurtado O., Castellanos M., Blanco M., Sobrino T., Serena J., Vivancos J., Castillo J., Lizasoain I., Moro M.A., Dávalos A. A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke. J. Exp. Med. March 20 2006, 203(3):711-717.
138. Anderson C.D., Biffi A., Greensberg S.M., Rosand J. Personalized approaches to clopidogrel therapy: Are we there yet?. Stroke 2010, 41:2997-3002.
139. Del Río-Espínola A., Fernández-Cadenas I., Giralt D., Quiroga A., Gutiérrez-Agulló M., Quintana M., Fernández-Álvarez P., Domingues-Montanari S., Mendióroz M., Delgado P., Turck N., Ruíz A., Ribó M., Castellanos M., Obach V., Martínez S., Freijo M.M., Jiménez-Conde J., Cuadrado-Godia E., Roquer J., Chacón P., Martí-Fábregas J., Sánchez J.C., GRECOS Investigators, Montaner J. A predictive clinical-genetic model of tissue plasminogen activator response in acute ischemic stroke. Ann. Neurol. Nov 2012, 72(5):716-729.
140. Parè G., Kubo M., Byrd J.B., McCarty C.A., Woodard-Grice A., Teo K.K., Anand S.S., Zuvich R.L., Bradford Y., Ross S., Nakamura Y., Ritchie M., Brown N.J. Genetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedema. Pharmacogenet. Genomics Sep 2013, 23(9):470-478.
141. Munot P., Crow Y.J., Ganesan V. Paediatric stroke: Genetic insights into disease mechanisms and treatment targets. Lancet Neurol. Mar 2011, 10(3):264-274. (Review). 10.1016/S1474-4422(10)70327-6.